The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $63.82

Today's change+1.23 +1.97%
Updated June 23 4:04 PM EDT. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $63.82

Today's change+1.23 +1.97%
Updated June 23 4:04 PM EDT. Delayed by at least 15 minutes.

NU Skin Enterprises Inc Hits New 100-day High

NU Skin Enterprises Inc closed up sharply Friday, rallying (U.S.)$1.23 or 1.97% to (U.S.)$63.82 and setting a new 100-day high. Over the last five days, shares have gained 9.13% and are currently 3.36% off of the 52-week high. Shares have outperformed the S&P 500 by 18.87% during the last year.

Key company metrics

  • Open(U.S.) $62.51
  • Previous close(U.S.) $62.59
  • High(U.S.) $65.00
  • Low(U.S.) $62.49
  • Bid / Ask-- / --
  • YTD % change+33.57%
  • Volume1,227,337
  • Average volume (10-day)702,027
  • Average volume (1-month)546,526
  • Average volume (3-month)921,542
  • 52-week range(U.S.) $42.97 to (U.S.) $66.04
  • Beta1.36
  • Trailing P/E21.39×
  • P/E 1 year forward20.47×
  • Forward PEG2.44×
  • Indicated annual dividend(U.S.) $1.44
  • Dividend yield2.26%
  • Trailing EPS(U.S.) $2.98
Updated June 23 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.48%

Based on its net profit margin of 7.48%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.65%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue499531604600
Total other revenue--------
Total revenue499531604600
Gross profit388423478472
Total cost of revenue111109126128
Total operating expense453471522521
Selling / general / administrative342362396392
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income46618280
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax42627769
Income after tax27385745
Income tax, total14242024
Net income27385745
Total adjustments to net income--------
Net income before extra. items27385745
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items27385745
Inc. avail. to common incl. extra. items27385745
Diluted net income27385745
Dilution adjustment--------
Diluted weighted average shares54555856
Diluted EPS excluding extraordinary itemsvalue per share0.510.700.980.79
Dividends per sharevalue per share0.360.360.360.36
Diluted normalized EPSvalue per share0.510.700.980.79